NASA says decision on Boeing Starliner crew's path home coming Saturday-March 2024-www.financetom.com

NASA says decision on Boeing Starliner crew's path home coming Saturday

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

NASA says decision on Boeing Starliner crew's path home coming Saturday

Aug 22, 2024 1:17 PM

WASHINGTON, Aug 22 (Reuters) - NASA on Thursday said it

expects to announce on Saturday its decision on whether the two

astronauts who rode Boeing's ( BA ) glitchy Starliner spacecraft to the

International Space Station will need a SpaceX vehicle to return

to Earth.

Previous page： Pinnacle West Capital's Q2 Earnings, Revenue Rise; Reaffirms 2024 EPS Guidance Next page： Immuno-Oncology Focused ALX Oncology Stock Falls On Updated Data From Mid-Stage Evorpacept Combo Study In Gastric Cancer Patients

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pinnacle West Capital's Q2 Earnings, Revenue Rise; Reaffirms 2024 EPS Guidance

Aug 1, 2024

09:02 AM EDT, 08/01/2024 (MT Newswires) -- Pinnacle West Capital ( PNW ) reported Q2 earnings Thursday of $1.76 per diluted share, up from $0.94 a year earlier. Analysts polled by Capital IQ expected $1.26. Operating revenue for the quarter ended June 30 was $1.31 billion, compared with $1.12 billion a year earlier. Three analysts surveyed by Capital IQ expected...

Immuno-Oncology Focused ALX Oncology Stock Falls On Updated Data From Mid-Stage Evorpacept Combo Study In Gastric Cancer Patients

Aug 1, 2024

On Wednesday, ALX Oncology Holdings Inc ( ALXO ). released topline data from its Phase 2 ASPEN-06 clinical trial. ASPEN-06 is evaluating evorpacept in combination with trastuzumab, Cyramza (ramucirumab), and paclitaxel (collectively, TRP) against TRP alone for HER2-positive gastric/GEJ cancer, where all patients had received an anti-HER2 agent in prior lines of therapy. The ASPEN-06 study is testing a new...

Kellanova raises 2024 forecasts on stable snacks demand in North America

Aug 1, 2024

(Reuters) - Kellanova ( K ) raised its annual organic sales and profit forecasts on Thursday as consumers opted for its breakfast cereals and ready-to-eat snacks such as Pringles despite higher prices. Shares of the company were up 4% before the bell, after it also beat Wall Street expectations for second-quarter results. The company, which previously made up Kellogg's (...

NNN REIT's Q2 Adjusted FFO, Revenue Rise; Lifts 2024 Guidance

Aug 1, 2024

09:02 AM EDT, 08/01/2024 (MT Newswires) -- NNN REIT ( NNN ) reported Q2 adjusted funds from operations Thursday of $0.84 per diluted share, compared with $0.80 a year earlier. Analysts surveyed by Capital IQ expected $0.83. Revenue for the quarter ended June 30 was $216.8 million, compared with $202.6 million a year earlier. Analysts surveyed by Capital IQ expected...